10.1016/s0891-5849(98)00315-3 119 RibeiroF.AlvesA
"And remember these are associations, not causations, so it's not to say that GLP-1 use causes NAION or worsening retinopathy, but their use is associated with these conditions." "From an ophthalmologic standpoint, these findings underscore the importance of baseline and follow-up eye examinations for patients starting GLP-1 therapy, especially those with pre-existing retinal or optic nerve risk factors." The expert added that while the benefits of GLP-1 medications in reducing cardiovascular and metabolic risks are "substantial," patients should be counseled on potential visual side effects, and "any sudden visual symptoms should prompt immediate ophthalmic referral." For more Health articles, visit www.foxnews.com/health Novo Nordisk, maker of Ozempic and Wegovy, provided the following statement when contacted by Fox News Digital
Endobronchial ultrasound (EBUS) During EBUS, your healthcare provider will look into your bronchioles (air tubes) using a bronchoscope
Shares were down moderately in 2025 through mid-April
Supports Metabolic Wellness: A blend of phytonutrients designed to support overall metabolic function
Discuss realistic expectations
